Urosepsis by multidrug-resistant Nakaseomyces glabratus with non-functional Erg3 and Erg11-do collateral sensitivity and a unique mode of action make nitroxoline a viable UTI antifungal?

18th September 2026

Carolus H, Biriukov V, Vreys J, Lobo Romero C, Herrera Avila JP, Vergauwen R, Sofras D, Nysten J, Vanreppelen G, Vinken L, Britto Xavier B, Gabaldón T, Lagrou K, Naesens R, Van Dijck P. Urosepsis by multidrug-resistant Nakaseomyces glabratus with non-functional Erg3 and Erg11-do collateral sensitivity and a unique mode of action make nitroxoline a viable UTI antifungal? mBio. 2026 May 20:e0058826. doi: 10.1128/mbio.00588-26. Epub 2026 May 20. PMID: 42159367.

Urosepsis by multidrug-resistant Nakaseomyces glabratus with non-functional Erg3 and Erg11-do collateral sensitivity and a unique mode of action make nitroxoline a viable UTI antifungal?

Urosepsis by multidrug-resistant Nakaseomyces glabratus with non-functional Erg3 and Erg11-do collateral sensitivity and a unique mode of action make nitroxoline a viable UTI antifungal?